Press Releases
Press Releases
-
November 9, 2019
New Data on Filgotinib in Rheumatoid Arthritis (RA) Demonstrate Durable Efficacy and Safety Profile -
November 8, 2019
Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting® 2019 -
November 8, 2019
Gilead Presents Data on Investigational HIV-1 Capsid Inhibitor GS-6207 as a Potential Component of Long-Acting HIV Therapy -
November 8, 2019
Data Showing Potential for Machine Learning to Advance Understanding of Nonalcoholic Steatohepatitis (NASH) Presented at the Liver Meeting® 2019 -
November 6, 2019
Kite to Present New Data From Industry-leading Cell Therapy Portfolio at ASH 2019 -
November 6, 2019
Gilead Presents 96-week Discover Trial Data Supporting Non-inferior Efficacy and Key Safety Differences of Descovy For PrEP™ Compared With Truvada For PrEP® -
November 6, 2019
Gilead’s Biktarvy Maintained High Efficacy With No Cases of Treatment-Emergent Resistance Through Three Years in Phase 3 HIV Clinical Trials -
October 31, 2019
Gilead and Galapagos to Present New Data on Filgotinib at 2019 ACR/ARP Annual Meeting -
October 28, 2019
Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development -
October 24, 2019
Gilead Sciences Announces Fourth Quarter 2019 Dividend